Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Labetalol to Prevent Hypertension and Tachycardia During Fiberoptic Bronchoscopy

NCT00394537 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT00394537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00394537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Labetalol to Prevent Hypertension and Tachycardia During Fiberoptic Bronchoscopy
Lead sponsor
Rabin Medical Center
Phase
Phase 4
Overall status
Completed
Start date
Not reported
Completion date
May 31, 2007
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchoscopy